South Carolina Measles Outbreak Declared over; Utah Reaches 625 Cases

Why It Matters

The twin stories underscore a resurgence of a vaccine‑preventable disease and illustrate how rapid immunization drives can curb spread, while gaps in coverage leave states vulnerable to prolonged outbreaks.

Key Takeaways

• South Carolina outbreak ends after 997 cases, 42‑day case‑free period.
• Statewide MMR vaccinations rose 31.1%, Spartanburg up 93.6% during outbreak.
• Utah measles cases climbed to 625, 428 reported in 2024.
• 92% of measles cases nationally are unvaccinated or unknown status.
• CDC records 1,487 U.S. cases this year, only 5% unvaccinated.

Pulse Analysis

The conclusion of South Carolina’s measles saga offers a clear example of how aggressive vaccination campaigns can reverse an epidemic. After the outbreak peaked at nearly a thousand cases, the state’s health department reported a 31.1% surge in MMR shots, with Spartanburg County—a hotspot—seeing vaccinations almost double. This rapid uptake not only protected vulnerable populations but also satisfied the CDC’s 42‑day no‑case rule, allowing officials to declare the outbreak officially over.

Utah, however, tells a different story. Since the first case in June 2025, the state has logged a steady climb to 625 confirmed infections, with 428 occurring this year alone. The incremental weekly updates reveal a pattern of persistent transmission, driven largely by pockets of unvaccinated individuals. Public health officials note that 92% of measles patients nationwide lack documented immunization, a statistic mirrored in Utah’s data, highlighting the challenges of achieving herd immunity in communities with vaccine hesitancy or limited access.

At the national level, the CDC’s tally of 1,814 measles cases in 2026 signals a broader resurgence of a disease once thought nearly eradicated in the United States. While only 5% of reported cases this year were confirmed as unvaccinated, the overwhelming majority remain either unvaccinated or with unknown status, suggesting underreporting and gaps in surveillance. The trend underscores the urgency for policymakers to reinforce school‑entry vaccine requirements, expand public education on MMR safety, and allocate resources for rapid response teams capable of containing future flare‑ups before they spread across state lines.